Enzon to halve staff by mid-2012 as it deals with setbacks
This article was originally published in Scrip
Executive Summary
The biotech firm Enzon Pharmaceuticals unveiled a plan to reduce its workforce over the coming months by half in order to keep costs aligned with its R&D goals.